1 in 4 U.S. adults has gotten a COVID-19 vaccine, plus other numbers from the vaccination effort

More than 60 million people in the U.S. have gotten at least one dose of COVID-19 vaccine and 31.3 million are fully vaccinated, the Centers for Disease Control and Prevention (CDC) reported Monday. The 92 million doses administered means 18.1 percent of the U.S. population has gotten at least one COVID-19 shot, and Andy Slavitt, a public health official who now works at the Biden White House, breaks that down by age group.
That means about 1 in 4 U.S. adults has been inoculated and 12 percent can now, the CDC suggests, resume some semblance of a normal social life. Here are some other numbers from the accelerating COVID-19 vaccination drive:
- 2.2 million COVID-19 shots now administered daily in the U.S., in the seven-day average
- 0 percent of Johnson & Johnson's one-shot vaccine included in the CDC's numbers as of Sunday night
- 44 percent of fully vaccinated U.S. adults, and about half of all adults, are anxious about re-entering normal life, according to soon-to-be published data from the American Psychological Association
- 25.8 percent of New Mexico's population has gotten at least one vaccine dose
- 15.8 percent of Alaska's population is fully vaccinated
- 13.3 percent of Georgia's population has gotten at least one vaccine dose
- 6.6 percent of Utah's population is fully vaccinated
- 100 percent of K-12 teachers are eligible to get vaccinated in the U.S. as of Monday — "though the situation is more straightforward in some states than others," The New York Times notes
- 312 million does (at least) have been administered worldwide in 116 countries, according to Bloomberg's tally.
The U.S. is making steady progress in its vaccination drive, Virginia Tech epidemiologist Lisa M. Lee tells The Wall Street Journal, but logistics continues to be the primary hurdle, "everything from secure and simple registration systems to directing traffic at large vaccination events."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
The Week contest: Amazon Bond
Puzzles and Quizzes
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published